[Federal Register Volume 79, Number 240 (Monday, December 15, 2014)]
[Notices]
[Pages 74097-74098]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-29289]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day 15-14AUI]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
WISEWOMAN National Program Evaluation--New--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The CDC has supported the WISEWOMAN program (Well-Integrated
Screening and Evaluation for Women Across the Nation) since 1995. The
WISEWOMAN program is designed to serve low-income women ages 40-64 who
have elevated risk factors for cardiovascular disease (CVD) and have no
health insurance, or are underinsured for medical and preventive care
services. Through the WISEWOMAN program, women have access to screening
services for selected CVD risk factors such as elevated blood
cholesterol, hypertension, and abnormal blood glucose levels; referrals
to lifestyle programs; and referrals to medical care. WISEWOMAN
participants must be co-enrolled in the CDC-sponsored National Breast
and Cervical Cancer Early Detection Program (NBCCEDP).
The WISEWOMAN program is administered through cooperative
agreements with state, territorial, or tribal health departments. At
present, approximately two-thirds of program funding is provided by CDC
with the other one-third supplied by the state, territory, or tribal
organization. Each WISEWOMAN awardee submits to CDC an annual progress
report that describes program objectives and activities, and semi-
annual data reports (known as minimum data elements, or MDE) on the
screening, assessment, and lifestyle program services offered to women
who participate in the program (see WISEWOMAN Reporting System, OMB No.
0920-0612, exp. 12/31/2016). Participant-level MDE are de-identified
prior to transmission to CDC.
In 2013, CDC released the fourth funding opportunity announcement
(FOA) for the WISEWOMAN program (DP13-1302), which resulted in four-
year cooperative agreements with 22 state, territorial, and tribal
health departments, including 5 new and 17 continuing awardees from the
previous FOA. Key program elements were retained (e.g., provision of
screening services, promotion of healthy lifestyle behaviors, and
linkage to community resources), but a number of changes were
incorporated into the program at that time due to shifts in
populations, systems, and community needs. The current FOA reflects
increased emphasis on improving access to clinical systems of care and
increased emphasis on leveraging existing resources in the community.
Lifestyle interventions have also been reframed to include lifestyle
programs and health coaching sessions, and MDE have been updated to
capture information about risk reduction counseling and participants'
readiness to change. The current cooperative agreement also stresses
monitoring and performance evaluation as key program dimensions.
Additionally, more information is needed to augment that from previous
evaluation efforts.
CDC seeks to conduct a one-time, multi-component evaluation to
assess the effectiveness of the program on individual-, organizational-
, and community-level outcomes. The in-depth assessment is designed to
complement the routine progress and MDE information already being
collected from WISEWOMAN program awardees. The new data collection will
focus on obtaining qualitative and
[[Page 74098]]
quantitative information at the organizational and community levels
about process and procedures implemented, and barriers, facilitators,
and other contextual factors that affect program implementation and
participant outcomes. Data collection activities will include a Program
Survey with all WISEWOMAN awardee programs, administered in the second
and fourth program years; a Network Survey of WISEWOMAN awardees and
partner organizations, also conducted in the second and fourth program
years; and a one-time Site Visit to a subset of awardees across the
second to fourth program years. During site visits, semi-structured
discussions will be conducted with WISEWOMAN staff and partner members
who serve in diverse roles and are positioned to provide a variety of
perspectives on program implementation.
OMB approval is requested for three years. Participation is
voluntary and there are no costs to respondents other than their time.
The total estimated annualized burden hours are 132.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hr)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Awardee Administrators...... Program Survey.......... 15 1 1
Network Survey.......... 15 1 30/60
Site Visit Discussion 6 1 75/60
Guide.
Awardee Partners...................... Network Survey.......... 147 1 30/60
Site Visit Discussion 12 1 45/60
Guide.
Healthy Behavior Support staff........ Site Visit Discussion 12 1 45/60
Guide.
Clinical Providers.................... Site Visit Discussion 12 1 45/60
Guide.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-29289 Filed 12-12-14; 8:45 am]
BILLING CODE 4163-18-P